Navigation Links
The First Dedicated Breast Cancer Cell Line Transfection Reagent
Date:4/3/2013

MADISON, Wis., April 3, 2013 /PRNewswire/ -- Mirus Bio has expanded its transfection expertise with the development of the TransIT-BrCa Transfection Reagent a high performance, low toxicity, DNA transfection reagent specifically formulated for breast cancer cell types. This new reagent offers users:

  • Superior DNA Delivery—Achieve high expression levels in breast cancer cell types including: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, T47D.
  • Formulated for Low Cellular Toxicity—Maintain cell density and reduce experimental biases due to toxicity.
  • Scientifically Proven—Developed by Mirus Bio scientists with nearly 2 decades of gene delivery expertise.

(Logo: http://photos.prnewswire.com/prnh/20100818/CG52502LOGO)

Mirus Bio is dedicated to advancing breast cancer research. In addition to providing scientists with state-of-the-art transfection reagents Mirus will donate a portion of every sale of TransIT-BrCa Transfection Reagent to the Breast Cancer Research Foundation.

Visit www.mirusbio.com for all your transfection needs including data, protocols, technical support or to place an order.

About Mirus Bio LLC –

ONE FOCUS: TRANSFECTION
Every transfection product offered by Mirus Bio is the result of scientific discovery and development from an in-house team of organic chemists, molecular biologists, cell biologists and biochemists. Almost two decades after its founding, transfection continues to be the focal point and passion of Mirus, giving researchers the most reliable products and expertise.


'/>"/>
SOURCE Mirus Bio LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
2. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
3. First Time in Philadelphia Is a Success for Pittcon 2013 (Summary Report)
4. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
5. Medifirst Solutions, Inc. Announces Further Update To Shareholders
6. BioMed Realty Trust Declares First Quarter 2013 Common Stock Dividend
7. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
8. First-To-File Patent Law Is Now In Effect, But What Does it Mean?
9. First Southeast Venture Philanthropy Summit Set In NC
10. Rigaku Raman Unveils Upgraded FirstGuard Handheld Analyzer with Industry’s Only 1064nm Wavelength Capabilities
11. First 3D Heads-Up Cataract Surgery Performed in Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa Therapeutics, ... B round of financing in the amount of $6 million. An investment vehicle ... in the round. , The Series B funding will enable Cybrexa to complete ...
(Date:6/14/2017)... ... June 14, 2017 , ... Slone Partners ... initiative steered by the executive search firm, “Building Value in Precision Medicine: Can ... Directors of Foundation Medicine, led an open discussion with expert panelists Troy Cox, ...
(Date:6/14/2017)... ... ... The newest company to join the Science Center’s Port business incubator is creating ... a spin out of the University of Michigan, will occupy lab space at 3624 ... Its founders are among the first wave of researchers adopting into translational science the ...
(Date:6/13/2017)... ... June 13, 2017 , ... Three newly formed companies have ... program. PolyCeramX, Recensa Therapeutics and Regennera, all P1V participants, will apply the funds ... Ventures is a startup accelerator that helps launch and grow companies that have ...
Breaking Biology Technology:
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):